Nasdaq: $26.59 (-0.59) | AIM: £3.91 (+0)
Search
EN
简
繁
About Us
Overview
Corporate Information
Board of Directors
Senior Management
Contact Us
What We Do
Overview
Research and Development
Commercialization
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Presentations
Recent News
All RNS & Press Releases
Presentations & Publications
Mailing List Sign-up
Shareholder Information
Overview
Events, Circulars & Forms
Major Shareholders
Financial Reports
SEC Filings
Share Price & Chart
Analyst Coverage
Dual-listing FAQs
Information for Shareholders
Warning to Shareholders
Terms of Reference & Policies
AIM Rule 26
Careers
About Us
Overview
Corporate Information
Board of Directors
Senior Management
Contact Us
What We Do
Overview
Research and Development
Commercialization
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Presentations
Recent News
All RNS & Press Releases
Presentations & Publications
Mailing List Sign-up
Shareholder Information
Overview
Events, Circulars & Forms
Major Shareholders
Financial Reports
SEC Filings
Share Price & Chart
Analyst Coverage
Dual-listing FAQs
Information for Shareholders
Warning to Shareholders
Terms of Reference & Policies
Audit Committee – Terms of Reference
AIM Rule 26
Careers
Shareholder Information
Hutchmed
| Shareholder Information
SHARE PRICE CHART
Nasdaq:HCM
US$26.59
-0.59 | 6 May 2021 | 16:00
Market cap (M): $3,959.33
London AIM:HCM
£3.91
+0 | 6 May 2021 | 08:00
Market cap (M): £2,911.06
MAJOR SHAREHOLDERS
Directors and Significant Shareholders
Financial Reports
Annual Reports (with 20-F) and Interim Reports
SEC Filings
EVENTS, CIRCULARS AND FORMS
Canaccord Genuity 2021 Horizons in Oncology Virtual Conference
2021-04-15
Morgan Stanley Virtual Hong Kong Summit
2021-03-30 - 2021-03-31
Annual General Meeting 2021
2021-04-28
Information for Shareholders
Share-related address & contact information
DUAL-LISTING FAQS
Frequently asked questions about HUTCHMED's UK and US share listings
AIM RULE 26 DISCLOSURES
Disclosure reference pursuant to Rule 26 'Company Information' of the AIM Rules of Companies
Warning to Shareholders
Avoiding share fraud
Analyst Coverage
Bloomberg
Cantor Fitzgerald
Goldman Sachs
Barclays
Bank of America Merrill Lynch
Canaccord Genuity
CLSA
Deutsche Bank
Edison
HSBC
Macquarie
Morgan Stanley
Panmure Gordon
Trinity Delta